Moderators: $$ Golden Cross $$ , G2G , DR. EVIL , captainscotty , HighYieldStocks , xlogit3k
Search This Board: 
Created: 07/28/2006 11:16:55 AM - Followers: 376 - Board type: Free - Posts Today: 0


Plandai Biotechnology, Inc.

Puriblood Medical Co., Ltd. [Taipei Exchange], develops and sells blood cell separation products including its leukocyte reduction filters for red blood cells, platelets, and whole blood, as well as real-time filtration sets for whole blood. The Puriblood Leukocyte Reduction Blood Filtration System helps ensure the quality of blood used for transfusions, by effectively removing Leukocytes from blood, thereby minimizing acute or delayed adverse transfusion reactions, including infection and death. Currently, approximately thirty countries around the world require leuko-reduction in blood supplies. Puriblood’s core blood purification filters reduce up to over 99% of leukocytes, in substantially less time, with minimal blood loss, while retaining a high level of red blood cells (where a higher number of red blood cells retained is desirable). Puriblood’s technology is patented in multiple strategic countries, including the United States, and cleared for marketing by the U.S. Food and Drug Administration under Section 510(k) of the Federal Food, Drug, and Cosmetic Act. Puriblood is a U.S. registered trademark of Puriblood Medical Co., Ltd. Corporation Taiwan 2f., No. 11, Gongye E. 9th Rd. Hsinchu County 30075 Taiwan R.O.C. 


Under the terms of the proposed agreement, the current holder of the worldwide rights, exclusive of Taiwan, Jessie Chiang, via entities she controls, will license to Plandai the exclusive rights to the Puriblood technology for North, Central, and South America for a period of 30 years. Upon closing of the proposed transaction, Ms. Chiang will acquire the controlling interest in the Company and will become the Company’s Director, President, and Chief Executive Officer. Ms. Chiang will then appoint new members to the board of directors and will move to establish a board of advisors consisting of leading industry, finance, and business experts. 

Tad Mailander, the Company’s CEO and director commented, “We have been very clear with our shareholders that Plandai has planned to create increased value by merging with another business entity or implementing a positive change in business direction via a new management team. We have been carefully vetting such opportunities, and we are now pleased to present this opportunity to our shareholders. We view this proposed transaction as being in the best interest of our shareholders. Our team is looking forward to completing our due diligence process and ultimately closing on this transaction.” 

Jessie Chiang commented: “This is an extremely exciting opportunity for the teams of our companies to all work together in synergy to maximize the potential of this frequently essential medical device in the international and domestic market.” 

The global leukapheresis market is primarily driven by solid growth in voluntary blood donations, rising incidence of hematologic diseases, such as leukemia, and an aging population in many countries. As a result, several industry analysts are forecasting continued strong growth in technologies and products designed for this market. For example, Quince Market Insights, in a report issued late in 2021, estimates the global leukapheresis market will grow at a compound annual growth rate of 43.9% until 2030. 

While the parties have agreed to non-binding terms in a letter outlining their intentions, the transaction has not yet been consummated, and there is no assurance that any such transaction will ultimately close. Plandai plans to release additional information concerning the progress of the proposed transaction as soon as possible, upon the completion of its due diligence investigation. 




Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#PLPL: CLEAN SHELL FOR SALE...! captainscotty 07/27/2022 10:46:15 AM
Sleepy time until news. Shhhh, don't wake up zombywolf 08/12/2022 02:37:50 PM
dead in the water RammageRaul 08/12/2022 11:57:52 AM
100 percent. The audited financials, should they marylandstockguy 08/10/2022 04:01:05 PM
Exactly - almost right where it was (I marylandstockguy 08/10/2022 03:55:02 PM
I actually like Tad now going into quiet Truenorth2016 08/10/2022 03:43:31 PM
Actually it's quite clear what is going on zombywolf 08/10/2022 02:38:43 PM
That's true and you've called me on that marylandstockguy 08/10/2022 11:10:18 AM
Each ticker has a behavior of its own Aquahoya 08/10/2022 11:08:23 AM
I think there's a good chance. Eco-tek marylandstockguy 08/10/2022 11:07:16 AM
I mean it's up to people. This stock Aquahoya 08/10/2022 11:04:03 AM
It looks that way? The volume is anemic marylandstockguy 08/10/2022 10:59:18 AM
I think its clear the MMs have moved Aquahoya 08/09/2022 07:46:22 PM
One day closer to fins, audit, SEC registration zombywolf 08/09/2022 07:43:05 PM
True - hoping we hear something there by marylandstockguy 08/09/2022 02:56:07 PM
Audited fins will be first IMO, and those zombywolf 08/09/2022 01:27:28 PM
We're in for a very long wait it marylandstockguy 08/09/2022 11:37:18 AM
6 on the ask, but no one is zombywolf 08/09/2022 11:13:48 AM
Is 6 on the ask? That's what I'm marylandstockguy 08/09/2022 10:33:45 AM
Looks like there are unlimited 5's to buy, zombywolf 08/09/2022 10:29:19 AM
Hmmm...was there just a mini-surge of volume? marylandstockguy 08/09/2022 10:29:07 AM
5 will be gone today konshe 08/09/2022 10:20:31 AM
The sooner they forget about last fail pump RammageRaul 08/09/2022 08:06:10 AM
PLPL is in the loading phase. This is Truenorth2016 08/09/2022 01:28:33 AM
Today's tradeing is good. Three time more buyers konshe 08/09/2022 12:22:08 AM
It's an interesting article for sure, but also marylandstockguy 08/08/2022 09:11:58 AM
Breakdown today from 0004 to 0002 -50% RammageRaul 08/08/2022 06:24:46 AM
Lol. zombywolf 08/07/2022 06:16:39 PM
This next run will be epic. After the zombywolf 08/07/2022 06:14:30 PM
Since it's a Bioscience company plpl should aquire rtrstock 08/07/2022 05:52:13 PM
.0016 to $2.22 run Tad Mailender, PLPL CEO Truenorth2016 08/07/2022 11:11:20 AM
You have zero idea what you own Patrick Bateman 08/07/2022 08:42:09 AM
What does that mean? Patrick Bateman 08/06/2022 09:17:38 PM
Hot air RammageRaul 08/06/2022 06:59:54 PM
Are you confusing good news as bad? zombywolf 08/06/2022 06:17:23 PM
This is why I own this… Patrick Bateman 08/06/2022 12:41:07 PM
They’re not apples and oranges. They’re the same. Patrick Bateman 08/05/2022 09:58:19 PM
Do you actually know what apples and oranges are? zombywolf 08/05/2022 07:09:07 PM
Again, how is it apples and oranges? This Patrick Bateman 08/05/2022 05:38:14 PM
I hear ya, that's the hope. I marylandstockguy 08/05/2022 03:19:35 PM
This is why you buy the P out zombywolf 08/05/2022 02:34:58 PM
I'm also a little suprised at Eco-Tek being marylandstockguy 08/05/2022 01:45:16 PM
That one is a good example of what zombywolf 08/05/2022 01:22:17 PM
They're an interesting one too. My two marylandstockguy 08/05/2022 01:01:11 PM
PLPL is #4 on BB, ready to take konshe 08/05/2022 12:57:08 PM
Lol / you’re buying thanks to the net Patrick Bateman 08/05/2022 12:32:36 PM
This has no income either. Do you know Patrick Bateman 08/05/2022 12:30:38 PM
I was literally about to type "I know marylandstockguy 08/05/2022 12:29:03 PM
The PLPL audit to me is bigger than Truenorth2016 08/05/2022 11:19:52 AM
You are talking about apples and oranges. Custodian zombywolf 08/05/2022 10:55:36 AM
5 is a good buy, only way is konshe 08/05/2022 10:43:04 AM
Post Subject